Combination of C1-INH and lung surfactant for the treatment of respiratory disorders

US7053176B1 · kind B1 · utility

Assignee

• ALTANA PHARMA AG · DE

Inventors

• Dietrich Hafner · Konstanz, DE
• Paul-Georg Germann · Bad Kötzting, DE
• Nils Ott · Hamburg, DE
• Burkhard Vangerow · Ronnenberg, DE
• Horst Rückoldt · Hannover, DE
• Gernot Marx · Aachen, DE
• Michael Cobas Meyer · Hannover, DE
• Martin Leuwer · Wunstorf, DE

Key dates

• Filing date: Sep 16, 1999
• Grant date: May 30, 2006
• Expiry date: Sep 16, 2019

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10T436/104165
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Pharmaceutical composition for the treatment of infant respiratory distress syndrome and acute lung injury (including adult respiratory distress syndrome) which contains C1 esterase inhibitor (C1-INH) and lung surfactant which comprises a lung surfactant protein.